Vis enkel innførsel

dc.contributor.authorAubert, Carole E.
dc.contributor.authorFloriani, Carmen
dc.contributor.authorBauer, Douglas C.
dc.contributor.authorda Costa, Bruno R.
dc.contributor.authorSegna, Daniel
dc.contributor.authorBlum, Manuel R.
dc.contributor.authorCollet, Tinh-Hai
dc.contributor.authorFink, Howard A.
dc.contributor.authorCappola, Anne R.
dc.contributor.authorSyrogiannouli, Lamprini
dc.contributor.authorPeeters, Robin P.
dc.contributor.authorÅsvold, Bjørn Olav
dc.contributor.authorDen Elzen, Wendy P.J.
dc.contributor.authorLuben, Robert N.
dc.contributor.authorBremner, Alexandra P.
dc.contributor.authorGogakos, Apostolos
dc.contributor.authorEastell, Richard
dc.contributor.authorKearney, Patricia M.
dc.contributor.authorHoff, Mari
dc.contributor.authorLe Blanc, Erin
dc.contributor.authorCeresini, Graziano
dc.contributor.authorRivadeneira, Fernando
dc.contributor.authorUitterlinden, André G.
dc.contributor.authorKhaw, Kay-Tee
dc.contributor.authorLanghammer, Arnulf
dc.contributor.authorStott, David J.
dc.contributor.authorWestendorp, Rudi G.J.
dc.contributor.authorFerrucci, Luigi
dc.contributor.authorWilliams, Graham R.
dc.contributor.authorGussekloo, Jacobijn
dc.contributor.authorWalsh, John P.
dc.contributor.authorAujesky, Drahomir
dc.contributor.authorRodondi, Nicolas
dc.date.accessioned2019-04-29T08:24:13Z
dc.date.available2019-04-29T08:24:13Z
dc.date.created2017-12-05T14:22:05Z
dc.date.issued2017
dc.identifier.citationJournal of Clinical Endocrinology and Metabolism. 2017, 102 (8), 2719-2728.nb_NO
dc.identifier.issn0021-972X
dc.identifier.urihttp://hdl.handle.net/11250/2595858
dc.description.abstractContext Hyperthyroidism is associated with increased fracture risk, but it is not clear if lower thyroid-stimulating hormone (TSH) and higher free thyroxine (FT4) in euthyroid individuals are associated with fracture risk. Objective To evaluate the association of TSH and FT4 with incident fractures in euthyroid individuals. Design Individual participant data analysis. Setting Thirteen prospective cohort studies with baseline examinations between 1981 and 2002. Participants Adults with baseline TSH 0.45 to 4.49 mIU/L. Main Outcome Measures Primary outcome was incident hip fracture. Secondary outcomes were any, nonvertebral, and vertebral fractures. Results were presented as hazard ratios (HRs) with 95% confidence interval (CI) adjusted for age and sex. For clinical relevance, we studied TSH according to five categories: 0.45 to 0.99 mIU/L; 1.00 to 1.49 mIU/L; 1.50 to 2.49 mIU/L; 2.50 to 3.49 mIU/L; and 3.50 to 4.49 mIU/L (reference). FT4 was assessed as study-specific standard deviation increase, because assays varied between cohorts. Results During 659,059 person-years, 2,565 out of 56,835 participants had hip fracture (4.5%; 12 studies with data on hip fracture). The pooled adjusted HR (95% CI) for hip fracture was 1.25 (1.05 to 1.49) for TSH 0.45 to 0.99 mIU/L, 1.19 (1.01 to 1.41) for TSH 1.00 to 1.49 mIU/L, 1.09 (0.93 to 1.28) for TSH 1.50 to 2.49 mIU/L, and 1.12 (0.94 to 1.33) for TSH 2.50 to 3.49 mIU/L (P for trend = 0.004). Hip fracture was also associated with FT4 [HR (95% CI) 1.22 (1.11 to 1.35) per one standard deviation increase in FT4]. FT4 only was associated with any and nonvertebral fractures. Results remained similar in sensitivity analyses. Conclusions Among euthyroid adults, lower TSH and higher FT4 are associated with an increased risk of hip fracture. These findings may help refine the definition of optimal ranges of thyroid function tests.nb_NO
dc.language.isoengnb_NO
dc.publisherOxford University Pressnb_NO
dc.titleThyroid function tests in the reference range and fracture: Individual participant analysis of prospective cohortsnb_NO
dc.title.alternativeThyroid function tests in the reference range and fracture: Individual participant analysis of prospective cohortsnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionpublishedVersionnb_NO
dc.source.pagenumber2719-2728nb_NO
dc.source.volume102nb_NO
dc.source.journalJournal of Clinical Endocrinology and Metabolismnb_NO
dc.source.issue8nb_NO
dc.identifier.doi10.1210/jc.2017-00294
dc.identifier.cristin1523105
dc.description.localcodeThis article will not be available due to copyright restrictions (c) 2017 by Oxford University Pressnb_NO
cristin.unitcode194,65,20,0
cristin.unitcode194,65,20,15
cristin.unitnameInstitutt for samfunnsmedisin og sykepleie
cristin.unitnameHelseundersøkelsen i Nord-Trøndelag
cristin.ispublishedtrue
cristin.fulltextpostprint
cristin.qualitycode2


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel